{"slug":"biovian","name":"Biovian","url":"https://www.gp-intel.com/company/biovian","sector":"Pharma","country":"France","hq_city":null,"website":"https://3pbiovian.com","founded_year":null,"ipo_year":null,"status":"pe_owned","current_owner":"Elyan Partners","current_holder":{"name":"Elyan Partners","names":["Elyan Partners"],"since_year":2018,"basis":"active_investor"},"ownership_periods":2,"ownership":[{"owner":"Edmond de Rothschild Private Equity (France)","fund":"Edmond de Rothschild Investment Partners BioDiscovery 4","fund_vintage":2015,"entry_year":2018,"exit_year":2024,"is_exit":true,"deal_type":"Recapitalization","buyer":"3P Biopharmaceuticals (combination created 3PBIOVIAN; ERES IV remained a minority shareholder)","moic":null,"sector":"Pharma"},{"owner":"Elyan Partners","fund":"ERES III","fund_vintage":2016,"entry_year":2018,"exit_year":null,"is_exit":false,"deal_type":null,"buyer":null,"moic":null,"sector":"Pharma"}],"source":"gp-intel.com","license":"CC-BY-4.0","updated_at":"2026-09-30T09:11:37.218Z"}